Brian Ramnaraign, MD FACP
@RamnaraignMD
Medical Oncologist at @UFHealthCancer and Assistant Professor of Medicine at @UF
ID:1129491380970151937
https://ufhealth.org/brian-h-ramnaraign 17-05-2019 20:58:24
323 Tweets
386 Followers
233 Following
In an OncLive.com interview, ilyas sahin, MD of UF Medicine discussed the potential use of Northstar Response in patients with advanced GI #cancer undergoing active treatment.
The study was presented at the ASCO 2024 GI Cancers Symposium. #GI24
Watch: onclive.com/view/dr-sahin-โฆ
Enfortumab vedotin as monotherapy in patients with #mCRPC : Results of stage I of a phase 2 trial. Presentation by Umang Swami Huntsman Cancer Institute. #GU24 written coverage by Rashid K. Sayyid University of Toronto > bit.ly/42f1P0D ASCO
Selecting Patients for Frontline CDK4/6 Inhibitors in Metastatic Breast Cancer ascopubs.org/doi/10.1200/ADโฆ #asco #asco dailynews #bcsm #MedTwitter #breastcancer ASCO MD Anderson Cancer Center
In an OncLive.com interview, UF Health oncologist Brian Ramnaraign, MD FACP discussed findings from a single-institution review of the incidence of immunotherapy-related toxicities in older patients with kidney #cancer :
onclive.com/view/dr-ramnarโฆ
Great Oral Abstract Session earlier today at #IKCSNA23 with presentation of the STELLAR-001 study with Sumanta K. Pal, MD, FASCO and the LITESPARK-013 study with pooja ghatalia as well as discussion on germline susceptibility of #kidneycancer and models of NF2 loss in HLRCC Kidney Cancer